Streetbeat News

Regulatory

OTC:PALAD

OTCQX:FCUUF

Paladin Energy's acquisition of Fission Uranium is under review by Canadian regulators due to national security concerns, particularly regarding Chinese investments. The deal, valued at $846 million, could significantly impact the uranium market by consolidating assets and influencing the global supply chain.

Portfolio Pulse from Stjepan Kalinic

October 02, 2024 | 8:58 pm

KNW

Know Labs has received a noncompliance notice from NYSE American for not meeting listing standards. The company plans to increase its valuation to regain compliance. Shares will continue trading with a ".BC" designation, indicating below compliance status. There is no immediate impact on business operations or SEC reporting requirements.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 8:31 pm

SPRO

Spero Therapeutics has published data from its Phase 1 study of SPR720, focusing on lung exposure, in the journal Antimicrobial Agents and Chemotherapy. This development is significant for the company's research in antimicrobial treatments.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 8:30 pm

UAL

The FAA has completed its review of United Airlines following several safety incidents earlier this year. The review found no significant safety issues, according to a statement to Bloomberg.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 8:30 pm

AMZN

The National Labor Relations Board (NLRB) has issued a formal complaint against Amazon, asserting that the company is a joint employer of its Delivery Service Partner drivers. This means Amazon has a legal obligation to recognize and negotiate with the Teamsters Union.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 8:30 pm

SNGX

Soligenix shares rise after reports of a potential Marburg virus case in Germany. The company previously received FDA orphan drug designation for MarVax, a treatment related to the virus.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 7:59 pm

SNGX

Traders are closely monitoring Soligenix as an article circulates about a police operation at a German train station due to fears of the Marburg virus. Soligenix has FDA Orphan Drug Status for its Marburg virus vaccine.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 7:48 pm

COIN

MSTR

Cryptocurrency markets, including Bitcoin, Ethereum, and Dogecoin, are experiencing a downward trend amid geopolitical uncertainties. Notable statistics show a decrease in large transaction volumes and a rise in daily active addresses. The crypto Fear and Greed Index is in the fear zone, and significant liquidations have occurred. Analysts are watching key support levels for Bitcoin, with potential for a rebound.

Portfolio Pulse from Khyathi Dalal

October 02, 2024 | 7:46 pm

DJT

SPY

U.S. prosecutors allege that Donald Trump planned to declare victory in the 2020 election before all ballots were counted if preliminary results showed him leading.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 7:43 pm

DIA

GLD

ITA

PPA

QQQ

SPY

USO

XAR

The geopolitical tensions between Israel and Iran have led to a risk-off sentiment in the markets, with concerns about oil supply disruptions. Major stock indices have slightly declined, while defense and oil-related ETFs have seen gains. The situation could impact inflation and central bank policies.

Portfolio Pulse from Anthony Noto

October 02, 2024 | 6:55 pm